This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Brown, C. E. et al. Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial. Nat. Med. https://doi.org/10.1038/s41591-024-02875-1 (2024)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. IL-13Rα2-targeted CAR T cells show promise in patients with recurrent high-grade gliomas. Nat Rev Clin Oncol 21, 335 (2024). https://doi.org/10.1038/s41571-024-00885-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-024-00885-z